Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Ivanyi, Philipp

Park-Simon, T.

Christiansen, H.

Gutzmer, R.

Vogel, A.

Heuser, M.

Golpon, H.

Hillemanns, P.

Haier, J.

Download
s10585-021-10083-1.pdf 404,14KB

Name

Value

Titel

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Autor/in

Erscheinungsjahr

2021

Publikationstyp

Artikel |

Online veröffentlicht

2021-03-23

Erschienen in

http://lobid.org/resources/99370676023406441#! |

Quellenangabe

38(3):257-261

Copyrightjahr

2021

Lizenz

https://creativecommons.org/licenses/by/4.0/ |

Verlagsversion

https://doi.org/10.1007/s10585-021-10083-1 |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987238/ |

Publikationsstatus

Postprint Verlagsversion |

Sprache der Publikation

Englisch |

Abstract/Summary

Cancer patients represent a vulnerable cohort during the Sars-CoV-2 pandemic. Oncological societies have generated a plethora of recommendations, but precise instructions about routine oncological procedures remain scarce. Here, we report on local COVID-19 protection measures established in an interdisciplinary approach at a tertiary care center during the first wave of the pandemia in Germany. Following these measures, no additional morbidity or mortality during oncological procedures was observed, and no nosocomial infections were registered. However, Validation of our measures is outstanding and regional SARS-CoV-2 prevalence was low. However, specific oncological measures might be important to ensure optimal oncological results, especially for advanced cancer stages during this and future pandemia. In the future, communication about these measures might be crucial to a cancer patient´s assigned network to reduce the danger of excess mortality within the second wave of the COVID-19 pandemic.

Sacherschließung

gnd 1206347392	COVID-19
lokal	Cancer
lokal	Infection Control/methods [MeSH]
lokal	Pandemics/prevention
lokal	Metastasis
lokal	Commentary
lokal	Germany/epidemiology [MeSH]
lokal	SARS-CoV-2/immunology [MeSH]
lokal	Prevalence [MeSH]
lokal	Treatment
lokal	COVID-19/epidemiology [MeSH]
lokal	Sars-CoV-19
lokal	SARS-CoV-2/pathogenicity [MeSH]
lokal	COVID-19/virology [MeSH]
lokal	Humans [MeSH]
lokal	Infection Control/organization
lokal	Medical Oncology/methods [MeSH]
lokal	Neoplasms/immunology [MeSH]
lokal	Tertiary Care Centers/organization
lokal	Medical Oncology/organization
lokal	COVID-19
lokal	Infection Control/standards [MeSH]
lokal	Neoplasms/complications [MeSH]
lokal	COVID-19/prevention
lokal	Pandemics/statistics
lokal	COVID-19/transmission [MeSH]
lokal	Medical Oncology/standards [MeSH]

Liste der Beteiligten

https://orcid.org/0000-0002-2862-7302|https://frl.publisso.de/adhoc/uri/UGFyay1TaW1vbiwgVC4=|https://frl.publisso.de/adhoc/uri/Q2hyaXN0aWFuc2VuLCBILg==|https://frl.publisso.de/adhoc/uri/R3V0em1lciwgUi4=|https://frl.publisso.de/adhoc/uri/Vm9nZWwsIEEu|https://frl.publisso.de/adhoc/uri/SGV1c2VyLCBNLg==|https://frl.publisso.de/adhoc/uri/R29scG9uLCBILg==|https://frl.publisso.de/adhoc/uri/SGlsbGVtYW5ucywgUC4=|https://frl.publisso.de/adhoc/uri/SGFpZXIsIEou

Hinweis

DeepGreen-ID: c5c3da7bb2a64515a4c1151a61b45e79 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)